MyAverix Finance
F · Healthcare
CARDIOL THERAPEUTICS CL.A (CT9)
Drug Manufacturers - Specialty & Generic
CARDIOL THERAPEUTICS CL.A (CT9) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $96.83M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CT9
CARDIOL THERAPEUTICS CL.A (CT9) — FAQ
What is CARDIOL THERAPEUTICS CL.A's market cap?
CARDIOL THERAPEUTICS CL.A (CT9) has a reported market cap of $96.83M (data as of 2026-03-28).
What is CT9's P/E ratio?
The price-to-earnings (P/E) ratio for CARDIOL THERAPEUTICS CL.A (CT9) is 18.00 (data as of 2026-03-28).
Does CARDIOL THERAPEUTICS CL.A pay a dividend?
Dividend yield is not available in the current snapshot for CARDIOL THERAPEUTICS CL.A (CT9). Check the MyAverix Finance app for the latest dividend data.
What sector is CARDIOL THERAPEUTICS CL.A in?
CARDIOL THERAPEUTICS CL.A (CT9) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is CT9 listed on?
CT9 is listed on F.
What is CARDIOL THERAPEUTICS CL.A's net margin?
CARDIOL THERAPEUTICS CL.A (CT9) reports a net margin of 0.0% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.